Estimating quality of life in a headache referral population based on Migraine Disability Assessment Scale and Headache Impact Test

  • Mansoureh Togha
  • Maral Seyed-Ahadi
  • Elham Jafari
  • Zahra Vahabi
  • Fereshteh Naderi-Behdani
  • Somayeh Nasergivehchi
  • Samaneh Haghighi
  • Zeinab Ghorbani
  • Fatemeh Farham
  • Seyed Mohammad Hassan Paknejad
  • Pegah Rafiee
Keywords: Disability Studies; Headache Disorders; Migraine Disorders; Quality of Life

Abstract

Background: Headache is among the most common disabling neurologic disorders. We measured quality of life in chronic migraine (CM) and episodic migraine (EM), stratified by medication overuse headache (MOH) and presence of aura.

Methods: In this observational study, conducted from January 2016 to December 2018, adult patients referred to the tertiary headache clinic of Sina Hospital in Tehran, Iran, who met International Classification of Headache Disorders,

3rd Edition-beta (ICHD-3 β) criteria for migraine were classified to EM and CM subtyped based on presence of aura and MOH. Validated Farsi versions of Migraine Disability Assessment Scale (MIDAS) and 6-item Headache Impact Test (HIT-6) questionnaires were used.

Results: A total of 2454 patients (1907 women) were enrolled from which 1261 (51.4%) patients had EM and 1193 (48.6%) had CM, while 908 subjects (37.0%) had MOH, of whom 890 (98.0%) had CM. Median scores of MIDAS and HIT-6 were significantly higher in patients with CM compared to EM sufferers. Chronic migraineurs with MOH had a significantly higher median score of MIDAS and HIT-6 compared to patients with non-MOH CM. Also, there was a moderate positive correlation between MIDAS (disability) and HIT-6 scores (impact on patients’ life) and a moderate correlation between HIT-6 and pain severity.

Conclusion: The results of this study confirm that CM and MOH are associated with a higher headache-related disability and impact on life compared to EM. Therefore, treatment goals in prevention of MOH and migraine transformation warrant higher quality of life in patients with migraine.

Published
2020-12-22
Section
Articles